Imaging Mental Disorders in the 21st Century

Johnstone EC Crow TJ Frith DC Cerebral ventricular size and cognitive impairment in schizophrenia. Lancet. 1976;2:924–926.

Zipursky RB Lim KO Sullivan EV Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 1992;49(3):195–205.

Marsh L Harris D Lim KO Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset. Arch Gen Psychiatry. 1997;54(12):1104–1112.

Cahn W Pol HE Hulshoff Lems EBTE Brain volume changes in first-episode schizophrenia: A 1-year follow-up study. Arch Gen Psychiatry. 2002;59(11):1002–1010.

Rapoport JL Giedd JN Blumenthal J Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 1999;56(7):649–654.

Lieberman JA Tollefson GD Charles C Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62(4):361–370.

Zipursky RB Christensen BK Mikulis DJ . Stable deficits in gray matter volumes following a first episode of schizophrenia. Schizophr Res. 2004;71(2–3):515–516.

Green AI Lieberman JA Hamer RM Olanzapine and haloperidol in first episode psychosis: Two-year data. Schizophr Res. 2006;86(1–3):234–243.

Keefe RS Seidman LJ Christensen BK Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry. 2006;59(2):97–105.

Weinberger DR McClure RK . Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: What is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59(6):553–558.

Serene JA Ashtari M Szeszko P Kumra S. Neuroimaging studies of children with serious emotional disturbances: A selective review. Can J Psychiatry 2007;52(3):135–145.

Zipursky RB Meyer JH Verhoeff NP . PET and SPECT imaging in psychiatric disorders. Can J Psychiatry 2007;52(3):146–157.

Kapur S Zipursky RB Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999;156(2):286–293.

Lieberman JA Stroup TS McEvoy JP Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–1223.

Jones PB Barnes TR Davies L Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry. 2006;63(10):1079–1087.

Pearlson G Calhoun V. Structural and functional magnetic resonance imaging in psychiatric disorders. Can J Psychiatry 2007;52(3):158–166.